In worms, melatonin promotes sleep by activating the BK channel through the MT1 receptor.
Researchers have created new 3D maps of two melatonin receptors. The models can be used to help develop new treatments that not only improve sleep, but may also treat a variety of other conditions from diabetes to cancer.
Researchers have identified how a mutation causes dysfunction in a protein, which inhibits neural activity and induces migraines.
According to a new study, synthetic chemicals found in some insecticides can bind to melatonin receptors, creating a higher risk for people to develop diabetes and other metabolic disorders.
